215 related articles for article (PubMed ID: 17663170)
1. [Gender, tumor localization and regional metastases as prognostic factors in combined and complex treatment of cutaneous melanoma].
Kudriavtsev DV; Mardynskiĭ IuS; Kudriavtseva GT
Vopr Onkol; 2007; 53(2):170-4. PubMed ID: 17663170
[TBL] [Abstract][Full Text] [Related]
2. [Prognostic significance of some markers in cutaneous melanoma treated with different therapeutic modalities].
Nepomniashchaia EM; Gusareva MA; Petrov SV
Vopr Onkol; 2008; 54(6):744-8. PubMed ID: 19241851
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors and impact of treatment in melanoma brain metastases: better prognosis for women?
Hofmann MA; Coll SH; Küchler I; Kiecker F; Wurm R; Sterry W; Trefzer U
Dermatology; 2007; 215(1):10-6. PubMed ID: 17587834
[TBL] [Abstract][Full Text] [Related]
4. Late recurrence of malignant melanoma: a report of five cases, a review of the literature and a study of associated factors.
Levy E; Silverman MK; Vossaert KA; Kopf AW; Bart RS; Golomb FM; Levenstein MJ
Melanoma Res; 1991; 1(1):63-7. PubMed ID: 1822771
[TBL] [Abstract][Full Text] [Related]
5. Clinical and histopathological risk factors to predict sentinel lymph node positivity, disease-free and overall survival in clinical stages I-II AJCC skin melanoma: outcome analysis from a single-institution prospectively collected database.
Mandalà M; Imberti GL; Piazzalunga D; Belfiglio M; Labianca R; Barberis M; Marchesi L; Poletti P; Bonomi L; Novellino L; Di Biagio K; Milesi A; Guerra U; Tondini C
Eur J Cancer; 2009 Sep; 45(14):2537-45. PubMed ID: 19553103
[TBL] [Abstract][Full Text] [Related]
6. Recurrent cutaneous melanoma: a surgical perspective.
Yeung RS
Semin Oncol; 1993 Oct; 20(5):400-18. PubMed ID: 8211191
[No Abstract] [Full Text] [Related]
7. Age and gender are significant independent predictors of survival in primary cutaneous melanoma.
Lasithiotakis K; Leiter U; Meier F; Eigentler T; Metzler G; Moehrle M; Breuninger H; Garbe C
Cancer; 2008 Apr; 112(8):1795-804. PubMed ID: 18306371
[TBL] [Abstract][Full Text] [Related]
8. [Adjuvant chemotherapy as a component of complex treatment for skin melanoma].
Kudriavtsev DV; Kudriavtseva GT; Mardynskiĭ IuS
Vopr Onkol; 2008; 54(2):170-7. PubMed ID: 18522165
[TBL] [Abstract][Full Text] [Related]
9. Acral lentiginous melanoma: a clinicoprognostic study of 126 cases.
Phan A; Touzet S; Dalle S; Ronger-Savlé S; Balme B; Thomas L
Br J Dermatol; 2006 Sep; 155(3):561-9. PubMed ID: 16911282
[TBL] [Abstract][Full Text] [Related]
10. [Influence of growth rates of local recurrences and in-transit metastases on survival of patients with cutaneous melanoma].
Mikhnin AE; Barchuk AS; Wagner RI; Anisimov VV
Vopr Onkol; 2004; 50(5):557-61. PubMed ID: 15715096
[TBL] [Abstract][Full Text] [Related]
11. Prognosis and determinants of outcome following locoregional or distant recurrence in patients with cutaneous melanoma.
Francken AB; Accortt NA; Shaw HM; Wiener M; Soong SJ; Hoekstra HJ; Thompson JF
Ann Surg Oncol; 2008 May; 15(5):1476-84. PubMed ID: 18196345
[TBL] [Abstract][Full Text] [Related]
12. [Melanoma in xeroderma pigmentosum: 12 cases].
Fazaa B; Zghal M; Bailly C; Zeglaoui F; Goucha S; Mokhtar I; Kharfi M; Ezzine N; Kamoun MR
Ann Dermatol Venereol; 2001 Apr; 128(4):503-6. PubMed ID: 11395647
[TBL] [Abstract][Full Text] [Related]
13. Does relative melanoma distribution by body site 1960-2004 reflect changes in intermittent exposure and intentional tanning in the Swedish population?
Dal H; Boldemann C; Lindelöf B
Eur J Dermatol; 2007; 17(5):428-34. PubMed ID: 17673388
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous melanoma in a multiethnic population: is this a different disease?
Hemmings DE; Johnson DS; Tominaga GT; Wong JH
Arch Surg; 2004 Sep; 139(9):968-72; discussion 972-73. PubMed ID: 15381614
[TBL] [Abstract][Full Text] [Related]
15. Prognostic scoring in patients with melanoma after adjuvant isolated limb perfusion.
Nagabhúshan JS; Murphy K; Angerson W; Kingsmore DB; Byrne DS; McKay AJ
J Surg Res; 2007 Mar; 138(1):22-4. PubMed ID: 17174339
[TBL] [Abstract][Full Text] [Related]
16. Ultraviolet B sensitivity of peripheral lymphocytes as an independent risk factor for cutaneous melanoma.
Pedeux R; Sales F; Pourchet J; Kallassy M; Fayolle C; Boniol M; Severi G; Ghanem G; Nakazawa HN; Autier P; Doré JF
Eur J Cancer; 2006 Jan; 42(2):212-5. PubMed ID: 16337788
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors influencing tumor response, locoregional control and survival, in melanoma patients with multiple limb in-transit metastases treated with TNFalpha-based isolated limb perfusion.
Di Filippo F; Giacomini P; Rossi CR; Santinami M; Anzà M; Garinei R; Perri P; Botti C; Di Angelo P; Sofra C; Pasqualoni R; Sperduti I; Cavaliere F; Di Filippo S; Corrias F; Armenti A; Ferraresi V; Ginebri A
In Vivo; 2009; 23(2):347-52. PubMed ID: 19414425
[TBL] [Abstract][Full Text] [Related]
18. Head and neck cutaneous melanoma: a retrospective observational study on 146 patients.
Koskivuo IO; Kinnunen IA; Suominen EA; Talve LA; Vihinen PP; Grénman RA
Acta Oncol; 2009; 48(3):460-7. PubMed ID: 18843562
[TBL] [Abstract][Full Text] [Related]
19. Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma.
Niakosari F; Kahn HJ; McCready D; Ghazarian D; Rotstein LE; Marks A; Kiss A; From L
Arch Dermatol; 2008 Apr; 144(4):462-7. PubMed ID: 18427039
[TBL] [Abstract][Full Text] [Related]
20. [Prognostic significance of DNA ploidy in disseminated malignant skin melanoma and the effectiveness of interleukin-2 (IL-2) treatment].
Novik AV; Novik BI; Moiseenko VM
Vopr Onkol; 2007; 53(2):164-9. PubMed ID: 17663169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
